Key Takeaways Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment Mounjaro…
Tag:
Drugs
- NewsStocks
Hims & Hers Shares Plunge as Costs Tied to Weight-Loss Drugs Squeeze Margins
by adminby adminShares of Hims & Hers Health (HIMS) plunged in late trading Monday after the company reported falling margins as costs rose, overshadowing…
Key Takeaways Shares of Incyte slumped Monday after the drugmaker’s fourth-quarter adjusted profit and 2025 sales forecasts missed analysts’ expectations. The company’s…
In his first week in office, President Trump tried to browbeat governments across the world into ending the flow of drugs into…
- NewsStocks
Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs
by adminby adminKey Takeaways Allurion Technologies said it planned to test its gastric balloon with the key ingredient in popular weight-loss drugs to see…
Key Takeaways Medicare will negotiate prices for Ozempic and 14 other drugs in 2025, with prices taking effect in 2026. Negotiations could…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The health…
- NewsStocks
Hims & Hers Stock Jumps as FDA Reconsiders Restrictions on Copycat Weight-Loss Drugs
by adminby adminKey Takeaways Hims & Hers shares gained Monday after the Food and Drug Administration said compounding pharmacies could continue to produce copycat…
Key Takeaways The S&P 500 ended 0.3% lower on Wednesday, Sept. 18, as the Federal Reserve announced its first interest-rate cut since…
Key Takeaways The S&P 500 rebounded on Thursday, Aug. 8, 2024, jumping 2.3% as fresh jobless claims data helped ease worries about…
Key Takeaways McKesson said that limited access to weight-loss treatments because of short supplies is negatively impacting its services sales. Fiscal 2025…
- AltcoinCryptocurrencyNews
BitcoinBlack deal brings crypto payments to telehealth, prescription drugs
by adminby adminCrypto card issuer BitcoinBlack announced that it had clinched a deal to buy telemedicine provider Ask the Doctor. The deal will enable…
- BusinessHealth CareNews
1 Biopharma Stock Setting the New Standard in Cancer Care Drugs
by adminby admin1 Biopharma Stock Setting the New Standard in Cancer Care Drugs Source Link
- NewsStocks
Hims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss Drugs
by adminby adminKey Takeaways Shares of telehealth company Hims & Hers skyrocketed Monday after the company announced plans to offer GLP-1 injections of a…